Home
 /
Papers
 /
Microbiology
 /
A dramatic protein fold switch powers a bactericidal nanomachine
Preprint
Open access
V1
Top 1% · Validated by QED

A dramatic protein fold switch powers a bactericidal nanomachine

Yao He, Annie Si Cong Li, Xiaoying Cai +7 more
January 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.01.28.702463
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Microbiology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By revealing that a massive coiled-coil-to-β-prism fold switch powers ATP-independent membrane puncture in a non-contractile bacteriocin, this work overturns assumptions about force generation in phage-like nanomachines and unlocks engineering of precision antimicrobials against drug-resistant pathogens.

QED claims analysis

Summary

The F7 pyocin bactericidal nanomachine employs a dramatic 163-residue coiled-coil to β-prism fold switch in its central fiber protein that powers membrane penetration through conformational energy release, representing an ATP-independent mechanism for bacterial killing that is conserved across diverse non-contractile phage tails through a characteristic SxSxxMxxLxS sequence motif.

See full analysis
Main Claim 1 –

F7 pyocin architecture: capped tail tube and five-protein tip

Supporting evidence

  • Tail terminator gene lies outside the pyocin operon
  • Side fibers stabilize central fiber coiled-coil via electrostatics
Main Claim 2 –

Central fiber 163-residue coiled-coil switches to β-prism

Main Claim 3 –

Cryo-ET shows fold-switching during bacterial surface interaction

Main Claim 4 –

Coiled-coil to β-prism switch is required for bactericidal activity

Supporting evidence

  • Fold-switch mutants assemble normally but lose killing in CFU assays
  • Fold-switch blockade abolishes membrane puncture measured by PI uptake
  • Fold switching enables tape measure protein ejection from tail tube

Abstract

Fold switching, where a protein region interconverts between entirely distinct three-dimensional structures, is emerging as vital for certain protein functions. Here, we report a remarkable example in the F7 pyocin, a phage tail-like bactericidal nanomachine. Cryogenic electron microscopy and tomography reveal that a 163-residue segment of the central tail fiber undergoes a dramatic transition—from a trimeric α-helical coiled-coil to a triangular β-prism—upon binding to the bacterial cell surface. This massive fold switch remodels the tail tip, ejects the internal tape measure protein, and drives membrane puncture. Site-directed mutations that selectively destabilize the β-prism conformation completely abolish bactericidal activity without impairing particle assembly, implying that the energy released during this transition powers penetration. AlphaFold-based analyses further predict similar large-scale coiled-coil to β-prism switches in diverse non-contractile phage tails. This discovery reveals a sophisticated, ATP-independent strategy for microbial warfare and opens exciting possibilities for engineering next-generation bacteriocins to combat multidrug-resistant pathogens.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?